Clinical Trials Logo

Filter by:
NCT ID: NCT03061500 Recruiting - Clinical trials for Intraabdominal Infections

Prognostic Value of Proadrenomedullin in Intra-abdominal Sepsis

Start date: October 15, 2016
Phase: N/A
Study type: Observational

An observational, prospective study whose main objective is to measure the value of Pro-adrenomedullin as a prognostic marker and predictor of mortality in patients with intra-abdominal sepsis after damage control surgery.

NCT ID: NCT03050476 Recruiting - Clinical trials for Systemic Inflammation

Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase

APPIRED-III
Start date: November 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Study should demonstrate that alkaline phosphatase reduces the incidence and extent of acute kidney injury after cardiopulmonary bypass (CPB) as defined by the AKIN criteria.

NCT ID: NCT03050333 Recruiting - Clinical trials for Gastrointestinal Neoplasms

Efficacy and Safety of Endoscopic Resection

Start date: April 25, 2013
Phase: N/A
Study type: Observational

An observational, prospective, multicentre and international study. This will be a non-interventional study to evaluate the efficacy and safety of endoscopic resection of gastrointestinal lesions and to determine what are the factors related to complications, and to describe these lesions according to the different morphologic and histologic classifications.

NCT ID: NCT03046108 Recruiting - Morton Neuroma Clinical Trials

Blind and Ultrasound Guided Injection in Morton Neuroma

Start date: January 2016
Phase: Phase 4
Study type: Interventional

The aim of this work trial is to compare the effectiveness of blind and ultrasound guided injection for Morton neuroma in order to determine which is more appropriate as the initial procedure in conservative treatment

NCT ID: NCT03044015 Recruiting - Clinical trials for Osteoporotic Fractures

Primary Care Based Intervention for the Secondary Prevention of Osteoporotic Fractures

APROP
Start date: January 2017
Phase: N/A
Study type: Interventional

BACKGROUND Recent evidence has been published about the effectiveness for the secondary prevention of osteoporotic fractures (OF) of the hospital-based fracture liaison services. AIM To assess the effectiveness of a primary care based intervention in the secondary prevention of OF. METHODOLOGY Prospective study of random clusters, defined at the primary-care trust (PCT) level. Total study follow-up 3 years. Sample size 1800 patients. DESCRIPTION To launch a defined strategy for the identification of OF. To carry out a primary care based intervention about lifestyle, diet and drug prescription, if needed, with an intensive follow-up in the intervention PCT vs treatment as usual in the control branch. ANALYSIS As the outcome are the new OF, a survival analysis will be done. Risk factors will be analyzed through Cox proportional hazard regression model stratified by age groups. Outcomes : - new OF ratio in intervention vs control areas. - maintenance of the adherence to the pharmacological and non pharmacological interventions proposed - assessment of cost-effectivity of the intervention

NCT ID: NCT03040973 Recruiting - Clinical trials for Advanced Solid Tumors Which Are cMET-dependent

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Start date: July 4, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess long-term safety and provide continued study treatment access to eligible participants who are judged by the Investigator to benefit from continued treatment with capmatinib monotherapy or in combination with other treatments or with the combination treatment alone in a Novartis sponsored study

NCT ID: NCT03036592 Recruiting - Clinical trials for Non-Diabetic Disorder of Endocrine Pancreas

MTNR1B SNP*Food Timing Interaction on Glucose Control

ONTIME-MT
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this investigation is to assess the role of melatonin receptor 1B (MTNR1B) single nucleotide polymorphism (SNP)*food timing interaction on glucose control in the deleterious effect in a vulnerable population with regular exposure to concurrent high melatonin and food intake as late night eaters (those having dinner within 2.5 h before their usual bed time). With the results from this study, we expect to advance our understanding of the role of endogenous melatonin on glucose metabolism in late night eaters and carriers of the MTNR1B risk allele, with potential implications on the guidelines to mitigate risk of type 2 diabetes in late night eaters and carriers of the MTNR1B risk allele.

NCT ID: NCT03034655 Recruiting - Fall Clinical Trials

Reducing Rate of Falls in Older People by Means of Vestibular Rehabilitation (ReFOVeRe Study)

ReFOVeRe
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate and compare the effectiveness of vestibular rehabilitation developed using computerized dynamic posturography or a mobile posturographic system with vibrotactile stimulation, to improve the balance in older people and reduce the number of falls.

NCT ID: NCT03032991 Recruiting - Clinical trials for Neurodevelopmental Disorders

Early Biomarkers of Neurodevelopment in Offspring of Diabetic Mothers

GD-BRAIN
Start date: January 2016
Phase: N/A
Study type: Observational

The prospective multicenter study GD-Brain provides a better knowledge on the basis of neurological impairment in children born to mothers with gestational diabetes (GDM). GDM modifies placental structure and affect materno-fetal nutrient transfer. Docosahexaenoic acid (DHA) play an important role on neurodevelopment, and it is reduced in venous cord blood of newborns born to GDM. In previous studies, we have already demonstrated impaired DHA fetal levels not only using label fatty acids with stable isotopes administrated to pregnant women, but also in observational studies in GDM as the prevention of obesity study (PREOBE study) in Granada and other similar study in Murcia. The impaired cord DHA levels were associated to disturbed neurodevelopment in these children during the first year of life. However, it is uncertain the mechanisms underlying this impaired materno-fetal DHA transfer and implications for later life. The recent publication in Nature Journal of a selective transmembrane carrier for DHA in brain named "major facilitator superfamily domain 2a" (MFSD2a) open new expectations. We detected disturbed MFSD2a levels in placentas from GDM which could be due to structural problems in this organ; inflammation, oxidation and metabolic changes related to diabetes might affect MFSD2a activity. Moreover, it is difficult to know whether disturbed MFSD2a levels in placenta may also indicate altered levels of this carrier in the brain from children born to GDM mothers, which could contribute to neurodevelopment impairment in these subjects. Recent studies also indicate that obesity alters the biosynthesis of eicosanoids derived from DHA, with a decrease of protectins and resolvin of D-series, which have powerful anti-inflammatory properties. The main aim of this study is to analyse potential differences on neurodevelopment, and brain structure and functioning, in children 8 years old born to GDM respect to those born to healthy normoweight mothers, as well as to identify early biomarkers consistently related to neurodevelopment from early stages of life.

NCT ID: NCT03014934 Recruiting - Clinical trials for Invasive Aspergillosis

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation

IPAT
Start date: January 2016
Phase:
Study type: Observational

Via a prospective non-interventional study clinical outcome of patients with - and without - history of pre-existing invasive aspergillosis undergoing allo-HSCT will be assessed, in terms of non-relapse mortality overall mortality and fungal infectious morbidity. Aim. Assessment of 1-year outcome of patients undergoing allo-HSCT with history of pre-existing IA vs. no pre-existing IA. Hypothesis. NRM in patients with pre-existing IA is not higher (by a specified margin of 10%) than patients without pre-existing IA. Study population. First allo-HSCT in patients with acute leukaemia and MDS given stem cell grafts. Cohort 1: History of probable or proven invasive aspergillosis Cohort 2: No History of probable or proven invasive aspergillosis: this cohort includes also the patient with a history of possible mycosis not documented microbiologically.